Pricing Log in Create free account

IN8bio, Inc. (INAB) vs Passage Bio, Inc. (PASG)

IN8bio, Inc. and Passage Bio, Inc. are both Biotechnology companies. IN8bio, Inc. and Passage Bio, Inc. are of similar size ($11.7M and $11.6M). Across the 9 metrics below, IN8bio, Inc. leads on 6 and Passage Bio, Inc. on 3.

Valuation

Metric INAB PASG Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 1.18 2.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.34 0.64
EV/Sales n/m n/m 9.21
Earnings yield (145.95%) (325.29%) (33.15%)
Free cash flow yield (67.71%) (326.67%) (25.50%)

Profitability

Metric INAB PASG Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (111.11%) (169.09%) (56.36%)
Return on assets (90.80%) (69.20%) (48.04%)
Return on invested capital (2,948.56%) 0.00% 0.00%

Growth

Metric INAB PASG Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 74.06% 32.94% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INAB PASG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.21 1.22 4.72
Net debt to EBITDA 1.56 0.96 0.96

Dividend

Metric INAB PASG Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric INAB PASG Biotechnology median
Market cap 11.68m 11.59m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack